Carvedilol Tablet, Film Coated
Product Images NDC 0093-0051

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 0093-0051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Carvedilol (Image 1)

Chemical structure of Carvedilol showing its molecular composition and arrangement of atoms, including aromatic rings and functional groups characteristic of this active ingredient.*

FDA Label Image

Figure 1 (Image 2)

A line graph comparing percentage mortality over 21 months between placebo and Carvedilol treatment groups. The graph shows separate lines for placebo and Carvedilol, with the placebo group having higher mortality. The x-axis represents time in months, and the y-axis shows percent mortality.*

FDA Label Image

Figure 2 (Image 3)

A forest plot chart showing hazard ratios with confidence intervals for various patient subgroups including men, women, age groups, racial groups, diabetic status, ischemic status, heart rate categories, systolic blood pressure categories, and spironolactone use, ending with an overall result for all patients. The x-axis depicts the hazard ratio scale.*

FDA Label Image

Figure 3 (Image 4)

A line graph comparing percent mortality over 24 months between Placebo and Carvedilol treatment groups. The x-axis shows time in months, and the y-axis shows percent mortality. The graph shows lower mortality for Carvedilol compared to Placebo, with a p-value of 0.03 indicating statistical significance.*

FDA Label Image

Figure 4 (Image 5)

A forest plot displaying hazard ratios with confidence intervals across various subgroups related to myocardial infarction (MI) outcomes. Subgroups include age, sex, timing of randomization post-MI, prior intravenous/oral beta-blocker use, Killip class, thrombolytic therapy, percutaneous transluminal coronary angioplasty (PTCA) for MI, current/prior congestive heart failure (CHF), diuretic use during MI, presence of angina, hypertension, diabetes, heart rate, systolic blood pressure (SBP), and all patients combined. Each subgroup presents hazard ratios with horizontal error bars along a labeled x-axis.*

FDA Label Image

Image (Image 6)

Label for Carvedilol Tablets USP 3.125 mg oral film-coated tablets by Teva Pharmaceuticals USA, Inc. The label indicates a package of 100 tablets and includes the NDC 0093-0051-01. The label instructs pharmacists to dispense with an attached patient information leaflet and notes prescription-only status.*

FDA Label Image

Image (Image 7)

Carvedilol Tablets USP 6.25 mg film-coated tablets label from Teva Pharmaceuticals USA, Inc. The label states the product is prescription only (Rx) and contains 100 tablets. It includes the NDC number 0093-0135-01 and instructs pharmacists to dispense with the attached patient information leaflet. Barcode and lot number details are also visible.*

FDA Label Image

Image (Image 8)

Carvedilol Tablets USP 12.5 mg film-coated tablets in a blister pack containing 100 tablets. The label includes the NDC 0093-7295-01 and indicates the product is for oral use, prescription only. Manufactured and labeled by Teva Pharmaceuticals USA, Inc.*

FDA Label Image

Image (Image 9)

Packaging label for Carvedilol Tablets USP 25 mg, film-coated oral tablets supplied by Teva Pharmaceuticals USA, Inc. The label indicates the product contains 100 tablets and includes the National Drug Code (NDC) 0093-7296-01. It features dosage and dispensing instructions along with a pharmacist caution to dispense with an attached patient information leaflet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.